ENTRY       D09219            Mixture   Drug
NAME        Telmisartan and hydrochlorothiazide (JP18);
            Micombi (TN);
            Micardis hct (TN)
PRODUCT     MICARDIS HCT (Boehringer Ingelheim Pharmaceuticals)
  GENERIC   TELMISARTAN AND HYDROCHLOROTHIAZIDE (Alembic Pharmaceuticals Limited)
            TELMISARTAN AND HYDROCHLOROTHIAZIDE (Alembic Pharmaceuticals)
            TELMISARTAN AND HYDROCHLOROTHIAZIDE (Aurobindo Pharma Limited)
            TELMISARTAN AND HYDROCHLOROTHIAZIDE (Glenmark Pharmaceuticals)
            TELMISARTAN AND HYDROCHLOROTHIAZIDE (Lupin Pharmaceuticals)
            TELMISARTAN AND HYDROCHLOROTHIAZIDE (Solco Healthcare LLC)
            TELMISARTAN AND HYDROCHLOROTHIAZIDE (Zydus Lifesciences Limited)
            TELMISARTAN AND HYDROCHLOROTHIAZIDE (Zydus Pharmaceuticals USA)
COMPONENT   Telmisartan [DR:D00627], Hydrochlorothiazide [DR:D00340]
CLASS       Cardiovascular agent
             DG01925  Renin-angiotensin system inhibitor
             DG03231  Antihypertensive
            Metabolizing enzyme substrate
             DG02924  UGT substrate
REMARK      Therapeutic category: 2149
            ATC code: C09DA07
            Product: D09219<JP/US>
EFFICACY    Antihypertensive
  DISEASE   Hypertension [DS:H01633]
COMMENT     Telmisartan is primarily metabolized by UDP-glucuronosyltransferase (UGT).
METABOLISM  Enzyme: UGT [KO:K00699]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             C CARDIOVASCULAR SYSTEM
              C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
               C09D ANGIOTENSIN II RECEPTOR BLOCKERS (ARBs), COMBINATIONS
                C09DA Angiotensin II receptor blockers (ARBs) and diuretics
                 C09DA07 Telmisartan and diuretics
                  D09219  Telmisartan and hydrochlorothiazide (JP18) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Cardiovascular Agents
              Cardiovascular Combinations
               Telmisartan/ Hydrochlorothiazide
                D09219  Telmisartan and hydrochlorothiazide (JP18)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              21  Cardiovascular agents
               214  Antihypertensives
                2149  Others
                 D09219  Telmisartan and hydrochlorothiazide (JP18)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01925  Renin-angiotensin system inhibitor
               D09219  Telmisartan and hydrochlorothiazide
              DG03231  Antihypertensive
               D09219  Telmisartan and hydrochlorothiazide
             Metabolizing enzyme substrate
              DG02924  UGT substrate
               D09219  Telmisartan and hydrochlorothiazide
            Drug classes [BR:br08332]
             Cardiovascular agent
              DG03231  Antihypertensive
               D09219  Telmisartan and hydrochlorothiazide
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D09219  Telmisartan and hydrochlorothiazide tablets
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D09219
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D09219
DBLINKS     PubChem: 96025899
///
